Table 2.
Statistics summarising patient characteristics, for the 620 assessments where this additional information was available, broken down by clinical site.
| Age in years | Disease duration in years | Sex | Medication | DBS | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean (SEM) | Q1–Q3 | Mean (SEM) | Q1–Q3 | Female | Male | Off | On | Yes | No | |
| DCMN | 59 (0.5) | 54–66 | 7 (0.4) | 3–9 | 86 | 209 | 179 | 116 | 34 | 261 |
| NRC | 61 (0.6) | 57–66 | 12 (0.5) | 9–14 | 40 | 116 | 42 | 114 | 117 | 39 |
| DRC | 66 (0.9) | 59–71 | 5 (0.3) | 3–7 | 41 | 45 | 8 | 78 | 1 | 85 |
| PDMDC | 63 (1.7) | 58–71 | 9 (0.6) | 6–10 | 15 | 22 | 30 | 7 | 0 | 37 |
| TSL | 52 (2.3) | 40–63 | 10 (0.6) | 7–12 | 9 | 37 | 10 | 36 | 46 | 0 |
| All sites | 61 (0.4) | 55–67 | 8 (0.2) | 4–11 | 191 | 429 | 269 | 351 | 198 | 422 |
For age and disease duration we show the mean and standard error of the mean (SEM) in years, as well as the lower to upper quartiles (Q1–Q3). We also show split by sex, medication (off-state vs on-state), and whether or not the patient had deep-brain stimulation at the time of assessment.